Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 10/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.75 |
| ▸ | POLH | Q9Y253 | 4/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.75 |
| ▸ | POLB | P06746 | 2/20 | 0.75 |
| ▸ | APEX1 | P27695 | 2/20 | 0.75 |
| ▸ | RECQL | P46063 | 2/20 | 0.75 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.75 |
| ▸ | RPS6KA3 | P51812 | 6/20 | 0.64 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.64 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30627917 | 1.00 | CYP3A4 (0.75) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL30627918 | 1.00 | CYP3A4 (0.75) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL4157325 | 0.91 | ABCB1 (0.76) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL31548920 | 0.91 | CYP3A4 (0.80) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL4175201 | 0.90 | POLH (0.76) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL31236662 | 0.90 | POLH (0.76) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL4161561 | 0.88 | CYP3A4 (0.65) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL4156001 | 0.87 | POLH (0.70) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL30627915 | 0.86 | TUBB4A (0.81) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| Isokaempferide SCHEMBL1628023 | 0.86 | POLH (1.00) | CYP3A4CYP2D6POLHKDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117560996-A | Flavor modifying compositions containing lactase | 弗门尼舍有限公司 | 2024-02-13 | — | — | CN | claimed |
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2009-05-21 | — | — | US | claimed |
| CN-115315195-B | Hydroxy-and methoxy-substituted flavonoids and use thereof | 弗门尼舍有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-115315194-B | Hydroxy-and methoxy-substituted flavones and use thereof | 弗门尼舍有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-117098460-A | Sweetener composition comprising mogrosides and uses thereof | 弗门尼舍公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116997263-A | Sweetener compositions comprising siamenoside I and uses thereof | 弗门尼舍公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116963609-A | Sweetener composition comprising mogrosides and uses thereof | 弗门尼舍公司 | 2023-10-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | CAT, NQO1, GPX4 | CYP3A4 518/4885CYP2D6 297/4885POLH 3392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.